Clinical Trial of an Anti-cancer Drug, CA-4948 (Emavusertib), in Combination With Chemotherapy Treatment (FOLFOX Plus Bevacizumab) in Metastatic Colorectal Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Seagen Inc.
Eli Lilly and Company
Pfizer
Pfizer
AstraZeneca
Novartis
City of Hope Medical Center
GlaxoSmithKline
Pfizer
Enliven Therapeutics
University of Alabama at Birmingham
Toray Industries, Inc
Jiangsu Hansoh Pharmaceutical Co., Ltd.
IGM Biosciences, Inc.
Memorial Sloan Kettering Cancer Center
Hansoh BioMedical R&D Company
Ohio State University Comprehensive Cancer Center
Merck Sharp & Dohme LLC
National Cancer Institute (NCI)
Ono Pharmaceutical Co. Ltd
Canadian Cancer Trials Group
Barbara Ann Karmanos Cancer Institute
Ludwig Institute for Cancer Research
Sumitomo Pharma Co., Ltd.
GSO Global Clinical Research BV
Gilead Sciences
Eli Lilly and Company
TG Therapeutics, Inc.
M.D. Anderson Cancer Center
Mayo Clinic
UNC Lineberger Comprehensive Cancer Center
University of Miami
University of Chicago
M.D. Anderson Cancer Center
Jiangsu Simcere Pharmaceutical Co., Ltd.
UNC Lineberger Comprehensive Cancer Center
National Cancer Institute (NCI)
Daiichi Sankyo
European Organisation for Research and Treatment of Cancer - EORTC
National Cancer Institute (NCI)
Memorial Sloan Kettering Cancer Center
Case Comprehensive Cancer Center
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
National Taiwan University Hospital
Wellstat Therapeutics